Cargando…
Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer
BACKGROUND: Ovarian cancer survival rates have not changed in the last 20 years. The majority of cases are High-grade serous ovarian carcinomas (HGSOCs), which are typically diagnosed at an advanced stage with multiple metastatic lesions. Taking biopsies of all sites of disease is infeasible, which...
Autores principales: | Martin-Gonzalez, Paula, Crispin-Ortuzar, Mireia, Rundo, Leonardo, Delgado-Ortet, Maria, Reinius, Marika, Beer, Lucian, Woitek, Ramona, Ursprung, Stephan, Addley, Helen, Brenton, James D., Markowetz, Florian, Sala, Evis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431480/ https://www.ncbi.nlm.nih.gov/pubmed/32804260 http://dx.doi.org/10.1186/s13244-020-00895-2 |
Ejemplares similares
-
Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering
por: Rundo, Leonardo, et al.
Publicado: (2020) -
Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer
por: Beer, Lucian, et al.
Publicado: (2020) -
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2023) -
Precision radiogenomics: fusion biopsies to target tumour habitats in vivo
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2021) -
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
por: Rundo, Leonardo, et al.
Publicado: (2022)